Physicians' Understanding of Clinical Trial Data in Professional Prescription Drug Promotion

References

1. 1.↵
   1. Kornfield R,
   2. Donohue J,
   3. Berndt ER,
   4. Alexander GC

   . Promotion of prescription drugs to consumers and providers, 2001–2010. PLoS One 2013;8:e55504.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Spurling GK,
   2. Mansfield PR,
   3. Montgomery BD,
   4. et al

   . Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med 2010;7:e1000352.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Marcatto F,
   2. Rolison JJ,
   3. Donatella F

   . Communicating clinical trial outcomes: effects of presentation method on physicians' evaluations of new treatments. Judgm Decis Mak 2013;8:29–33.

   OpenUrl
4. 4.↵
   1. Bobbio M,
   2. Demichelis B,
   3. Giustetto G

   . Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet 1994;343:1209–11.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Bucher H,
   2. Weinbacher M,
   3. Gyr K

   . Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 1994;309:761–4.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Kahwati L,
   2. Carmody D,
   3. Berkman N,
   4. Sullivan HW,
   5. Aikin KJ,
   6. DeFrank J

   . Prescribers' knowledge and skills for interpreting research results: a systematic review. J Contin Educ Health Prof 2017;37:129–36.

   OpenUrl
7. 7.↵
   1. West CP,
   2. Ficalora RD

   . Clinician attitudes toward biostatistics. Mayo Clin Proc 2007;82:939–43.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Windish DM,
   2. Huot SJ,
   3. Green ML

   . Medicine residents' understanding of the biostatistics and results in the medical literature. JAMA 2007;298:1010–22.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Walker JL

   . The use of saturation in qualitative research. Can J Cardiovasc Nurs 2012;22:37–41.

   OpenUrlPubMed